BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17105841)

  • 1. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Dziura J; Duleba AJ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):456-61. PubMed ID: 17105841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial.
    Duleba AJ; Banaszewska B; Spaczynski RZ; Pawelczyk L
    Fertil Steril; 2006 Apr; 85(4):996-1001. PubMed ID: 16580386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome.
    Minozzi M; Costantino D; Guaraldi C; Unfer V
    Gynecol Endocrinol; 2011 Nov; 27(11):920-4. PubMed ID: 21417594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
    Glintborg D; Altinok ML; Mumm H; Hermann AP; Ravn P; Andersen M
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2584-91. PubMed ID: 24742124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
    Kaya C; Pabuccu R; Cengiz SD; Dünder I
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):161-6. PubMed ID: 20146169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
    Mastorakos G; Koliopoulos C; Creatsas G
    Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
    Yousuf SD; Rashid F; Mattoo T; Shekhar C; Mudassar S; Zargar MA; Ganie MA
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):58-62. PubMed ID: 27381237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD; Hunter T; Stuckey B; Hart RJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome].
    Banaszewska B; Spaczyński RZ; Ozegowska K; Pawelczyk L
    Ginekol Pol; 2011 Jun; 82(6):430-5. PubMed ID: 21853932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial.
    Moretti C; Guccione L; Di Giacinto P; Simonelli I; Exacoustos C; Toscano V; Motta C; De Leo V; Petraglia F; Lenzi A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):824-838. PubMed ID: 29211888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
    Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
    Harmanci A; Cinar N; Bayraktar M; Yildiz BO
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):120-5. PubMed ID: 22702394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
    Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
    J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C; Muderris II
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.